Answers are grounded in this paper and cite their sources.
Evaluates aflibercept 8 mg efficacy in patients with macular conditions, implying potential treatment advancements.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: